Using qRT-PCR, Cochetti et al. suggested a panel of serum microRNAs that could distinguish PCa from benign prostatic hyperplasia in age-matched patients with elevated PSA levels [10]. The gene discussed is KLK3; the disease is posterior cortical atrophy.